摘要
贫血在充血性心力衰竭患者中是常见的,发病率从4%到55%不等。其发病机制可能与血液稀释、营养不良、肾功能不全、炎症性免疫激活等因素有关。贫血与充血性心力衰竭患者的临床预后密切相关,并被认为是心力衰竭患者临床预后不良的独立因子。应用促红细胞生成素和静脉铁剂成为治疗充血性心力衰竭性贫血的新靶点。
Anemia is common in congestive heart failure（CHF） patients, with a prevalence ranging from 4% to 55% depending on the population studied. Multiple potential mechanisms of interaction exist between anemia and congestive heart failure, including hemedilution, malnutrition, renal insufficiency and inflammatory immunity activation. Anemia is closely related to clinical prognosis of CHF and is considered to be an independent predictor of poor prognosis in CHF patients. The use of subcutaneous erythropoietin and intravenous iron for the treatment of anemia in CHF has become a new target.
出处
《国际内科学杂志》
CAS
2008年第1期30-33,共4页
International Journal of Internal Medicine
